Risk factors for gestational diabetes mellitus in polycystic ovary syndrome patients at different gestation
返回论文页
|更新时间:2023-12-22
|
Risk factors for gestational diabetes mellitus in polycystic ovary syndrome patients at different gestation
Journal of Chongqing Medical UniversityVol. 43, Issue 2, Pages: 245(2018)
作者机构:
1. 重庆医科大学附属第一医院妇产科,重庆,400016
2. 重庆市沙坪坝区妇幼保健计划生育服务中心妇产科,重庆,400030
作者简介:
基金信息:
DOI:
CLC:
Published:2018,
扫 描 看 全 文
Chen Jun, Luo Ying, Zhou Zhengqin. Risk factors for gestational diabetes mellitus in polycystic ovary syndrome patients at different gestation. [J]. Journal of Chongqing Medical University 43(2):245(2018)
DOI:
Chen Jun, Luo Ying, Zhou Zhengqin. Risk factors for gestational diabetes mellitus in polycystic ovary syndrome patients at different gestation. [J]. Journal of Chongqing Medical University 43(2):245(2018)DOI:
Risk factors for gestational diabetes mellitus in polycystic ovary syndrome patients at different gestation
Objective:To investigate the risk factors for gestational diabetes mellitus(GDM) in polycystic ovary syndrome(PCOS) at different gestation,and to further understand the clinical characteristics of PCOS complicated with GDM. Methods:Pregnant women diagnosed with PCOS in the Obstetrics and Gynecology Department of Maternal and Child Health Care Family Planning Service Center of Shapingba District of Chongqing and received standard treatment and prenatal care services during March 2013 to March 2015 were included. According to the result of oral glucose tolerance test at 24th week and 32nd week of gestation,aforementioned pregnant women were divided into GDM group(n=20 at 24 weeks of gestation,n=28 at 32 weeks of gestation) and Non-GDM group(n=77 at 24 weeks of gestation,n=69 at 32 weeks of gestation). Their basic information and the differences in the level of androgen and insulin in each group were compared,and the risk factors for GDM were analysed. Results:At 24th week of gestation,there were significant differences in the weight gain and level of insulin between GDM group and Non-GDM group [the weight gain in GDM group is (5.54±1.32) kg,while in Non-GDM group is (4.08±0.91) kg,t=2.487,P=0.015;the concentration of insulin in GDM group is (30.35±8.70) pmol/L,while in Non-GDM group is (25.47±7.56) pmol/L,t=3.289,P=0.001]. At 32nd week of gestation,there were significant differences in the weight gain,family history of diabetes,the level of testosterone and insulin between GDM group and Non-GDM group [the weight gain in GDM group is (9.83±0.91) kg,while in Non-GDM group is (8.61±1.23) kg,t=2.283,P=0.025;patients with family history of diabetes in GDM group are 10 cases,while in Non-GDM group are 9 cases, ?字2=3.939,P=0.047;the concentration of testosterone in GDM group is (3.49±1.65) nmol/L,while in Non-GDM group is (2.46±1.17) nmol/L,t=2.542,P=0.013;the concentration of insulin in GDM group is (33.78±7.01) pmol/L,while in Non-GDM group is (27.12±6.39) pmol/L,t=4.108,P=0.000]. Logistics regression analysis showed that both the higher weight gain and level of insulin were independent risk factors for GDM in PCOS pregnant women(OR=2.467,95%CI=1.912 to 3.355,P=0.029;OR=1.565,95%CI=1.287 to 1.921,P=0.007) at 24th week of gestation;while the higher weight gain and level of testosterone and insulin were independent risk factors for GDM in PCOS pregnant women(OR=2.640,95%CI=2.392 to 3.588,P=0.033;OR=1.587,95%CI=1.103 to 3.307,P=0.045;OR=2.735,95%CI=1.182 to 4.803,P=0.001) at 32nd week of gestation. Conclusions:Higher weight gain and level of insulin are risk factors for GDM in PCOS pregnant women at second trimester and third trimester. Furthermore,higher level of testosterone is a risk factor for GDM in PCOS pregnant women at third trimester.
Clinical efficacy of Liraglutide combined with metformin in overweight or obese patients with PCOS
Comparison of remission of metformin,pioglitazone and their combination on early abnormal glucose metabolism in patients with polycystic ovary syndrome
A mouse model of polycystic ovary syndrome with abnormal glucose and lipid metabolism induced by dihydrotestosterone combined with high-fat diet
Risk factors of contrast-induced nephropathy in patients with diabetes after percutaneous coronary intervention and its prognosis
Development and validation of an insulin sensitivity score in female with polycystic ovary syndrome
Related Author
Liao Mingyu
Shen Rufei
Liao Qian
Zhou Ling
Ran Chenxi
Li Xiaorong
Min Long
Liu Qicong
Related Institution
Department of Endocrinology,The Second Affiliated Hospital of Army Medical University
Department of Endocrinology,The First Affiliated Hospital of Army Medical University
Endocrinology and Metabolism Department,The Second Affiliated Hospital of Chongqing Medical University
Department of Endocrinology,Chongqing Traditional Chinese Medicine Hospital
Department of Endocrinology,The Second Affiliated Hospital of Chongqing Medical University